Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Neoplasms of the CNS

  Free Subscription


29.01.2024

2 Acta Neuropathol
1 Am J Clin Oncol
5 BMC Cancer
1 BMC Neurol
2 Br J Cancer
1 Cancer Res
1 Clin Cancer Res
2 Eur J Cancer
5 J Neurooncol
2 J Neuropathol Exp Neurol
1 J Neurosurg
6 Neuro Oncol
1 Neuroradiology
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. NEYAZI S, Yamazawa E, Hack K, Tanaka S, et al
    Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.
    Acta Neuropathol. 2024;147:22.
    PubMed         Abstract available

  2. DREXLER R, Khatri R, Schuller U, Eckhardt A, et al
    Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.
    Acta Neuropathol. 2024;147:21.
    PubMed         Abstract available


    Am J Clin Oncol

  3. PAN WK, Ren SY, Zhu LX, Lin BC, et al
    A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.
    Am J Clin Oncol. 2023 Oct 23. doi: 10.1097/COC.0000000000001058.
    PubMed         Abstract available


    BMC Cancer

  4. QIAN J, He Z, Wu Y, Li H, et al
    Analysis of the efficacy of upfront brain radiotherapy versus deferred radiotherapy for EGFR/ALK-positive non-small cell lung cancer with brain metastases: a retrospective study.
    BMC Cancer. 2024;24:117.
    PubMed         Abstract available

  5. LIU JS, Cai YX, He YZ, Xu J, et al
    Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
    BMC Cancer. 2024;24:123.
    PubMed         Abstract available

  6. LU Y, Liao L, Du K, Mo J, et al
    Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma.
    BMC Cancer. 2024;24:133.
    PubMed         Abstract available

  7. YANG W, Han Y, He C, Zhong S, et al
    Association between psychiatric disorders and glioma risk: evidence from Mendelian randomization analysis.
    BMC Cancer. 2024;24:118.
    PubMed         Abstract available

  8. ZHU X, Liu Y, Guo W, Liang Q, et al
    Epidemiology, characteristics, and prognostic factors of lymphoplasmacyte-rich meningioma: a systematic literature review.
    BMC Cancer. 2024;24:110.
    PubMed         Abstract available


    BMC Neurol

  9. BAYE ND, Baye FD, Teshome AA, Ayenew AA, et al
    Incidence and predictors of early posttraumatic seizures among patients with moderate or severe traumatic brain injury in Northwest Ethiopia: an institution-based prospective study.
    BMC Neurol. 2024;24:41.
    PubMed         Abstract available


    Br J Cancer

  10. MOGENSEN H, Tettamanti G, Frederiksen LE, Talback M, et al
    Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden.
    Br J Cancer. 2024;130:260-268.
    PubMed         Abstract available

  11. HEYMER EJ, Hawkins MM, Winter DL, Teepen JC, et al
    Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Br J Cancer. 2024 Jan 19. doi: 10.1038/s41416-024-02577.
    PubMed         Abstract available


    Cancer Res

  12. UNDERHILL HR, Karsy M, Davidson CJ, Hellwig S, et al
    Subclonal Cancer Driver Mutations are Prevalent in the Unresected Peritumoral Edema of Adult Diffuse Gliomas.
    Cancer Res. 2024 Jan 25. doi: 10.1158/0008-5472.CAN-23-2557.
    PubMed         Abstract available


    Clin Cancer Res

  13. LIM-FAT MJ, Iorgulescu JB, Rahman R, Bhave V, et al
    Clinical and genomic predictors of adverse events in newly diagnosed glioblastoma.
    Clin Cancer Res. 2024 Jan 22. doi: 10.1158/1078-0432.CCR-23-3018.
    PubMed         Abstract available


    Eur J Cancer

  14. MANDALA M, Lorigan P, Sergi MC, Benannoune N, et al
    Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.
    Eur J Cancer. 2024;199:113542.
    PubMed         Abstract available

  15. DI GIACOMO AM, Chiarion-Sileni V, Del Vecchio M, Ferrucci PF, et al
    Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial.
    Eur J Cancer. 2024;199:113531.
    PubMed         Abstract available


    J Neurooncol

  16. GONZALEZ-APONTE MF, Damato AR, Trebucq LL, Simon T, et al
    Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma.
    J Neurooncol. 2024 Jan 26. doi: 10.1007/s11060-023-04535.
    PubMed         Abstract available

  17. KREATSOULAS D, Damante M, Cua S, Lonser RR, et al
    Adjuvant convection-enhanced delivery for the treatment of brain tumors.
    J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-023-04552.
    PubMed         Abstract available

  18. MULLER SJ, Khadhraoui E, Ganslandt O, Henkes H, et al
    MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis.
    J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-024-04573.
    PubMed         Abstract available

  19. GARCIA MA, Turner A, Brachman DG
    The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.
    J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-023-04523.
    PubMed         Abstract available

  20. REESE JC, Fadel HA, Pawloski JA, Samir M, et al
    Laser interstitial thermal therapy for deep-seated perivascular brain tumors is not associated with distal ischemia.
    J Neurooncol. 2024 Jan 19. doi: 10.1007/s11060-023-04546.
    PubMed         Abstract available


    J Neuropathol Exp Neurol

  21. FENG Y, Xu H, Hu X, Zhang J, et al
    Heterogenous driving genetic events contribute to the dissemination of choroid plexus papilloma.
    J Neuropathol Exp Neurol. 2024;83:131-135.
    PubMed        

  22. XI S, Huang Q, Zeng J
    A novel grading system combining histological grade and CDKN2A homozygous and hemizygous deletion to predict prognosis in IDH-mutant astrocytoma.
    J Neuropathol Exp Neurol. 2024;83:125-130.
    PubMed         Abstract available


    J Neurosurg

  23. HUA L, Alkhatib M, Fujio S, Alhasan B, et al
    Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study.
    J Neurosurg. 2024 Jan 26:1-7. doi: 10.3171/2023.11.JNS231936.
    PubMed         Abstract available


    Neuro Oncol

  24. ZIEGLER DS, Lehmann R, Eisenstat DD
    A paradigm shift in how we treat pediatric low grade glioma - targeting the molecular drivers.
    Neuro Oncol. 2024 Jan 19:noae008. doi: 10.1093.
    PubMed        

  25. DANKNER M, Maritan SM, Priego N, Kruck G, et al
    Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes.
    Neuro Oncol. 2024 Jan 25:noae013. doi: 10.1093.
    PubMed         Abstract available

  26. RANDALL J, Sachdev S
    A valuable glioblastoma prognostic maker driven by radiosensitivity.
    Neuro Oncol. 2024 Jan 23:noad266. doi: 10.1093.
    PubMed        

  27. MOON HH, Jeong J, Park JE, Kim N, et al
    Generative AI in glioma: ensuring diversity in training image phenotypes to improve diagnostic performance for IDH mutation prediction.
    Neuro Oncol. 2024 Jan 22:noae012. doi: 10.1093.
    PubMed         Abstract available

  28. SUN Y, Mu G, Xue Z, Wang S, et al
    Polyunsaturated fatty acid-binding protein FABP7, an attractive metabolic target for inhibition of glioblastoma stem cells.
    Neuro Oncol. 2024 Jan 19:noad238. doi: 10.1093.
    PubMed        

  29. LIU RZ, Choi WS, Godbout R
    Nuclear translocation matters: Role of FABP7 in driving glioblastoma stemness and invasion: Reply to Mu et al.
    Neuro Oncol. 2024 Jan 19:noad239. doi: 10.1093.
    PubMed        


    Neuroradiology

  30. YAMASHITA K, Togao O, Kikuchi K, Kuga D, et al
    The cortical high-flow sign of oligodendroglioma, IDH-mutant and 1p/19q-codeleted: comparison between arterial spin labeling and dynamic susceptibility contrast methods.
    Neuroradiology. 2024;66:187-192.
    PubMed         Abstract available


    PLoS One


  31. Retraction: MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene.
    PLoS One. 2024;19:e0297950.
    PubMed        

  32. WOHLSEIN JC, Meurer M, Morgelin M, Nessler JN, et al
    Neutrophil extracellular traps in CSF and serum of dogs with steroid-responsive meningitis-arteritis.
    PLoS One. 2024;19:e0295268.
    PubMed         Abstract available

  33. DE VILLIERS O, Elliot-Wilson C, Thomas KGF, Semple PL, et al
    Sleep and cognition in South African patients with non-functioning pituitary adenomas.
    PLoS One. 2024;19:e0296387.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.